Mundipharma market exit
Mundipharma advised that it is leaving the Aotearoa New Zealand market.
29 July 2024 update
New suppliers for oxycodone tablets and oral liquid have entered the market.
Products we're still seeking a resolution for
Chemical name | Stock available until | Presentation | Brand | Pharmacode | Update |
---|---|---|---|---|---|
Morphine sulphate | June 2025 | Tab immediate-release 10 mg | Sevredol | 2520990 | No disruption of supply is expected. Distribution has moved to a new supplier |
Morphine sulphate | June 2025 | Tab immediate-release 20 mg | Sevredol | 2521008 | No disruption of supply is expected. Distribution has moved to a new supplier |
Resolved products
Chemical name | Update | Presentation | Previous Brand | Previous Pharmacode | Update |
---|---|---|---|---|---|
Dihydrocodeine tartrate | No supply outage expected | Tab long-acting 60 mg | DHC Continus | 772887 | Pharmaco is the new supplier |
Oxycodone hydrochloride | Amneal is the new brand | cap 5 mg Immediate release | OxyNorm | 2179741 | OxyNorm Medicine notice |
Oxycodone hydrochloride | Amneal is the new brand | cap 10 mg immediate release | OxyNorm | 2179768 | OxyNorm Medicine notice |
Oxycodone hydrochloride | Amneal is the new brand | cap 20 mg immediate release | OxyNorm | 2179776 | OxyNorm Medicine notice |
Oxycodone hydrochloride | Oxycodone Lucis available | oral liq 5 mg per 5 ml | OxyNorm | 2243687 | Morphine Oral Liquid Medicine notice |
Delisted items
Chemical name | Presentation | Brand | Pharmacode | Resolution |
---|---|---|---|---|
Timolol | Eye drops 0.5%, gel forming | Timoptol XE | 204374 |
Restricted to no new patients 1 April 2023. Delisted 1 March 2024 |
Dorzolamide hydrochloride | Eye drops 2% | Trusopt | 285226 |
Restricted to no new patients 1 April 2023. Delisted 1 March 2024 |
What Pharmac is doing
Pharmac is considering multiple options for products currently supplied by Mundipharma. We will update this page with information about what is happening with each product.
We are working closely with Mundipharma and other suppliers to ensure as little disruption as possible for people using Mundipharma's products.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)